Comparing Fascia Iliaca Compartment Block and Pericapsular Nerve Group Block for Hip Fracture Pain Control

March 21, 2024 updated by: Sheng-Chin Kao, Mackay Memorial Hospital

Comparing Fascia Iliaca Compartment Block With Pericapsular Nerve Group Block for Hip Fracture Pain Control Before Operation

The aim of the study is to compare the analgesic effect of fascia iliaca compartment block (FIC) block and pericapsular nerve group (PENG) block in hip fracture pain control. The participants, caregivers, and assessors will be blinded to the type of block the participants receive. Patients aged 20 years or older with hip fracture scheduled for surgical treatment will be assessed for eligibility to participate the study. One hundred eligible patients will be included in the study after informed consents are obtained, and then randomly allocated into either FIC block or PENG block, with 50 patients in each group. Both blocks will performed under ultrasound guidance.

The followings will be assessed: the numerical rating pain scale (NRS 0-10, 0: no pain, 10: worst pain imaginable) at before and after nerve block at different time points during rest and passive internal rotation of the fractured lower limb to neutral position from its typical external rotation deformity 30 mins after block (primary outcome). The degree of patient's satisfaction regarding nerve blocks and anesthesiologist's satisfaction regarding patient position during spinal anesthesia will also be assessed. The pain and use of rescue analgesics in the first 24 hours after operation will be recorded.

Study Overview

Detailed Description

The aim of this study is to compare the analgesic effect of fascia iliaca compartment block (FIC) block and pericapsular nerve group (PENG) block in hip fracture pain control before operation.

Methods This will be a randomized, assessor and participant-blinded study. After the patients give his /her informed consents, his/her baseline demographic data (gender, age, height, and body weight) and types of hip fracture will be recorded. Participants will be randomly allocated into either FIC block or PENG block by using the website RESEARCH RANDOMIZER (https://www.randomizer.org). One of the two anesthesiologists experienced in performed the FIC and PENG blocks will perform the nerve blocks. Only the anesthesiologist performing the nerve block and his assistant will be aware of which nerve block the participant receives immediately before performing nerve block by opening a sealed envelope. The assessors, in-charge anesthesiologists and nurse anesthetists, operation room personnel, surgeons and study participants will be all blinded to the randomization.

On arrival of the operating theater, all participants will be sent to the nerve block area, where continuous electrocardiogram, pulse oximetry, and non-invasive intermittent blood pressure monitoring will be applied and an intravenous line will be established. Before any intervention, pain at rest and during the fractured lower limb being passively internal rotated in extension to neutral position from its usual externally rotated deformity by assessors will assessed using NRS. If the participant cannot tolerate passive internal rotation of his/her fractured limb due to pain, impossibility to perform the test will be recorded as well as the worst NRS score during these attempts. The same assessment will be performed every 10 mins for until 30 mins after completion of the nerve block. Then the patient will be sent to the operation room, where spinal anesthesia will be performed for the surgery.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • New Taipei City, Taiwan, 25160
        • Mackay Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Scheduled for surgical treatment for hip fracture
  • American Society of Anesthesiologists (ASA) physical status I-III

Exclusion Criteria:

  • allergy to local anesthetics
  • pregnancy
  • inability to understand and use the numerical rating scale (NRS 0-10, 0: no pain, 10: worst pain imaginable) after instruction
  • chronic use of opioids
  • coagulopathy
  • neuropathy
  • severe diabetic mellitus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Fascia iliaca compartment block
Participants will receive fascia iliaca compartment block before spinal anesthesia and operation
A linear ultrasound transducer is placed in a sagittal plane to identify the anterior superior iliac spine. By sliding the transducer medially, the fascia iliaca and abdominal internal oblique, sartorius, and iliopsoas muscles are identified. After identifying the "bow-tie sign", a 23-gauge needle (7mm, Nipro, Japan) is inserted in plane from caudal to cephalad until the needle tip penetrate the fascia iliaca. After negative aspiration, 0.35% ropivacaine 30mL with 1:400,000 epinephrine will be injected to separate the fascia iliaca and the iliacus muscle.
Experimental: Pericapsular nerve group block group
Participants will receive pericapsular nerve group block before spinal anesthesia and operation
A curvilinear ultrasound transducer is initially place on the anterior inferior iliac spine and then aligned to the iliopubic eminence by rotating around 45 degree. In this view, the iliopubic eminence, iliapsoas muscle and tendon, pectineus muscle, femoral artery and vein will be identified. A 23-gauge needle (7mm, Nipro, Japan) is inserted in plane from lateral to medial until the needle tip in the musculofascial plane between the psoas tendon anteriorly and the pubic ramus posteriorly. After negative aspiration, 0.35% ropivacaine 20mL with 1:400,000 epinephrine will be injected.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain measurement at rest
Time Frame: 30 minutes after nerve blocks
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable) at rest
30 minutes after nerve blocks
Pain measurement during internal rotation
Time Frame: 30 minutes after nerve blocks
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable) during the fractured limb being passively internally rotated to neutral position from usual externally rotated deformity
30 minutes after nerve blocks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain measurement at rest
Time Frame: 10 minutes after nerve block
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable) at rest
10 minutes after nerve block
Pain measurement during internal rotation
Time Frame: 10 minutes after nerve block
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable) during the fractured limb being passively internally rotated to neutral position from usual externally rotated deformity
10 minutes after nerve block
Pain measurement at rest
Time Frame: 20 minutes after nerve block
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable) at rest
20 minutes after nerve block
Pain measurement during internal rotation
Time Frame: 20 minutes after nerve block
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable) during the fractured limb being passively internally rotated to neutral position from usual externally rotated deformity
20 minutes after nerve block
pain measurement during positioning for spinal anesthesia
Time Frame: Just before operation
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable) during changing position from supine to lateral decubitus with flexion of the healthy hip
Just before operation
pain measurement after operation
Time Frame: 6, 12, and 24 hours after operation
Numerical pain rating scale (0-10, 0: no pain, 10: worst pain imaginable)
6, 12, and 24 hours after operation
the time spending for performing spinal anesthesia
Time Frame: Just before operation
defined as starting of positioning maneuver to removal of spinal needle
Just before operation
quality of position for spinal anesthesia
Time Frame: Just before operation
characterized as unsatisfied, satisfied, good, and excellent by the anesthesiologists performing the spinal anesthesia
Just before operation
the first time of pain perceived by the patient after operation
Time Frame: Within 48 hours after operation
the time interval between the end of operation and pain first perceived by the patient
Within 48 hours after operation
the time of first request for rescue analgesics after operation
Time Frame: Within 48 hours after operation
the time interval between the end of operation and the first request for rescue analgesics
Within 48 hours after operation
total consumption of rescue analgesics within 24 hours after the operation
Time Frame: Within 24 hours after the operation
total consumption of rescue analgesics within 24 hours after the operation
Within 24 hours after the operation
the first time of ambulation after operation
Time Frame: Within 72 hours after operation
the time interval between the end of operation and the first time the patient can ambulate with assistance after operation
Within 72 hours after operation
the time spending for nerve block
Time Frame: Before operation
defined as from contact of skin by the ultrasound transducer to removal of the needle
Before operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sheng-Chin Kao, MD, Mackay Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2020

Primary Completion (Actual)

May 31, 2023

Study Completion (Actual)

June 4, 2023

Study Registration Dates

First Submitted

December 19, 2019

First Submitted That Met QC Criteria

December 21, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Actual)

March 22, 2024

Last Update Submitted That Met QC Criteria

March 21, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 19MMHIS254e

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on Fascia iliaca compartment block

3
Subscribe